Current Opioid Access, Use, and Problems in Central and Western European Jurisdictions

AbstractPurpose of the ReviewTo provide recent data on opioid use in Central and Western Europe and available treatments, with focus on Spain and Switzerland.Recent FindingsThe prevalence of opioid use in Europe is around 0.4%, which represents 1.3 million individuals. Heroin use remains the main reason for treatment among patients with an opioid use disorder (>  80%). Opioid agonist treatment (OAT) is generally available, with methadone and buprenorphine being the most often used treatments. In some European countries, pharmaceutical heroin (diacetylmorphine, DAM) is also available as an OAT option.SummaryThe prevalence of opioid use disorder is decreasing in Western Europe and OAT is widely available. Heroin remains the opioid of most concern but changes in the prevalence of use of other opioids should be closely monitored.
Source: Current Addiction Reports - Category: Addiction Source Type: research